UNITED GUARDIAN INC

United-Guardian, Inc., operating through its Guardian Laboratories division, develops, manufactures, and markets specialty ingredients and healthcare products. Its offerings comprise cosmetic ingredients, medical lubricants, pharmaceutical products, and sexual wellness ingredients. The company produces hydrogel formulations under the Lubrajel brand for cosmetic and medical applications, including catheter lubrication and oral care, alongside natural cosmetic lines certified to organic standards. Its pharmaceutical line includes Renacidin, an FDA-approved prescription drug used to prevent and dissolve catheter calcifications, and Clorpactin, a topical antimicrobial. United-Guardian sells its cosmetic ingredients globally through commercial distributors and supplies its medical lubricants directly to medical device manufacturers. It distributes its prescription drugs within the United States primarily through national drug wholesalers supplying hospitals and pharmacies.

The company operates a manufacturing facility and executive offices in Hauppauge, New York, where all products except Renacidin are produced. It markets its products domestically across the United States as well as to international distributor networks.

Summary of the business section of United Guardian's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“We currently have twenty-five employees, three of whom serve in an executive capacity, one in marketing, sixteen in research, quality control and manufacturing, two in maintenance and construction, and three in office and administrative support services.”